Individual provider · Type 1 NPI
Emmanuelle Sivilay
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist · El Monte, CA
NPI number
1417469420
Active
Practice location
10953 Ramona Blvd
El Monte, CA 91731-2629
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Pharmacist | 183500000X | 77814 (CA) |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Primary | 1835P0018X | 77814 (CA) |
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist: Pharmacist Clinician/Clinical Pharmacy Specialist is a pharmacist with additional training and an expanded scope of practice that may include prescriptive authority, therapeutic management, and disease management.
129 other providers at this address
- County of Los AngelesClinic/Center El Monte, CA NPI 1073124244
- County of Los AngelesClinic/Center El Monte, CA NPI 1528079233
- County of Los AngelesClinic/Center El Monte, CA NPI 1932239621
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1245360932
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1326051087
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1417134644
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1417960170
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1477899292
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1508879263
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1841320538
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1861731218
- County of Los Angeles Auditor ControllerClinic/Center El Monte, CA NPI 1881607547
Other pharmacist clinician (phc)/ clinical pharmacy specialist providers in El Monte
About NPI 1417469420
Emmanuelle Sivilay's National Provider Identifier is 1417469420, issued on Oct 31, 2017. The primary taxonomy on file is Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist (1835P0018X), and the practice location is in El Monte, CA. The record was last updated on Oct 30, 2024.